Trial Profile
Clinical Trials Insight: 700022173
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Apr 2007
Price :
$35
*
At a glance
- Drugs INCB 15050 (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Incyte Corporation
- 03 Apr 2007 New trial record.